Search research articles
Contact Us
Filters
Showing results (11-20 of 86) with videos related to
Page
of 9
Sort By:
Hepatic Medicine : Evidence and Research
|
November 15, 2023
COVID-19 and the Liver: A Complex and Evolving Picture
Simon D Taylor-Robinson, Marsha Y Morgan
The Cochrane Database of Systematic Reviews
|
April 19, 2016
Non-absorbable disaccharides versus placebo/no intervention and lactulose versus lactitol for the prevention and treatment of hepatic encephalopathy in people with cirrhosis
Lise Lotte Gluud, Hendrik Vilstrup, Marsha Y Morgan
Clinics in Liver Disease
|
July 7, 2021
Genetic and Environmental Susceptibility to Alcoholic Hepatitis
Marsha Y Morgan, Moksh Sharma, Stephen R Atkinson
Hepatology (Baltimore, Md.)
|
April 16, 2016
Nonabsorbable disaccharides for hepatic encephalopathy: A systematic review and meta-analysis
Lise L Gluud, Hendrik Vilstrup, Marsha Y Morgan
Metabolic Brain Disease
|
September 22, 2007
Therapeutic studies in hepatic encephalopathy
Kevin D Mullen, Piero Amodio, Marsha Y Morgan
BMJ (Clinical Research Ed.)
|
February 13, 2009
Hemiparesis in a 36 year old man
Michael V Holmes, Atul Mehta, Marsha Y Morgan
Journal of Clinical and Experimental Hepatology
|
July 31, 2019
Outcomes in Clinical Trials Evaluating Interventions for the Prevention and Treatment of Hepatic Encephalopathy
Lise L Gluud, Rebecca Jeyaraj, Marsha Y Morgan
The Cochrane Database of Systematic Reviews
|
May 7, 2016
Non-absorbable disaccharides versus placebo/no intervention and lactulose versus lactitol for the prevention and treatment of hepatic encephalopathy in people with cirrhosis
Lise Lotte Gluud, Hendrik Vilstrup, Marsha Y Morgan
Metabolic Brain Disease
|
November 24, 2004
Characteristics of minimal hepatic encephalopathy
Piero Amodio, Sara Montagnese, Angelo Gatta, et al.
Journal of Hepatology
|
February 21, 2017
Tools and tactics for improving the diagnosis of hepatic encephalopathy
Søren S Olesen, Clive D Jackson, Marsha Y Morgan
Page
of 9
Search research articles
Search
Showing results (11-20 of 86) with videos related to
Sort By:
Page
of 9
Hepatic Medicine : Evidence and Research
|
November 15, 2023
COVID-19 and the Liver: A Complex and Evolving Picture
Simon D Taylor-Robinson, Marsha Y Morgan
The Cochrane Database of Systematic Reviews
|
April 19, 2016
Non-absorbable disaccharides versus placebo/no intervention and lactulose versus lactitol for the prevention and treatment of hepatic encephalopathy in people with cirrhosis
Lise Lotte Gluud, Hendrik Vilstrup, Marsha Y Morgan
Clinics in Liver Disease
|
July 7, 2021
Genetic and Environmental Susceptibility to Alcoholic Hepatitis
Marsha Y Morgan, Moksh Sharma, Stephen R Atkinson
Hepatology (Baltimore, Md.)
|
April 16, 2016
Nonabsorbable disaccharides for hepatic encephalopathy: A systematic review and meta-analysis
Lise L Gluud, Hendrik Vilstrup, Marsha Y Morgan
Metabolic Brain Disease
|
September 22, 2007
Therapeutic studies in hepatic encephalopathy
Kevin D Mullen, Piero Amodio, Marsha Y Morgan
BMJ (Clinical Research Ed.)
|
February 13, 2009
Hemiparesis in a 36 year old man
Michael V Holmes, Atul Mehta, Marsha Y Morgan
Journal of Clinical and Experimental Hepatology
|
July 31, 2019
Outcomes in Clinical Trials Evaluating Interventions for the Prevention and Treatment of Hepatic Encephalopathy
Lise L Gluud, Rebecca Jeyaraj, Marsha Y Morgan
The Cochrane Database of Systematic Reviews
|
May 7, 2016
Non-absorbable disaccharides versus placebo/no intervention and lactulose versus lactitol for the prevention and treatment of hepatic encephalopathy in people with cirrhosis
Lise Lotte Gluud, Hendrik Vilstrup, Marsha Y Morgan
Metabolic Brain Disease
|
November 24, 2004
Characteristics of minimal hepatic encephalopathy
Piero Amodio, Sara Montagnese, Angelo Gatta, et al.
Journal of Hepatology
|
February 21, 2017
Tools and tactics for improving the diagnosis of hepatic encephalopathy
Søren S Olesen, Clive D Jackson, Marsha Y Morgan
Page
of 9